David Steinberg
Stock Analyst at Jefferies
(2.82)
# 1,856
Out of 4,974 analysts
35
Total ratings
59.26%
Success rate
20.07%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $7.35 | +8.84% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $22.65 | +178.15% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $46.01 | -13.06% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $129.50 | +45.17% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $13.60 | -41.18% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $5.57 | +115.44% | 2 | Jun 14, 2018 | |
| SVRA Savara | Initiates: Buy | $20 | $3.72 | +437.63% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $7.35
Upside: +8.84%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $22.65
Upside: +178.15%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $46.01
Upside: -13.06%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $129.50
Upside: +45.17%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $13.60
Upside: -41.18%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $5.57
Upside: +115.44%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $3.72
Upside: +437.63%